Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 143, 2023 - Issue 8
Submit an article Journal homepage
593
Views
0
CrossRef citations to date
0
Altmetric
Otoneurology

Intratympanic dexamethasone in Manières disease and symptom control

Tatjana Tomanovica Department of ENT-Hearing and Balance, Karolinska University Hospital, Huddinge, Stockholm, Sweden;b Department ENT, Karolinska Institutet, CLINTEC, Stockholm, SwedenCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0009-0001-5722-7893
ORCID Icon
Pages 681-686 | Received 19 Jun 2023, Accepted 24 Jul 2023, Published online: 08 Sep 2023

References

  • Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease. American Academy of otolaryngology-head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995;113(3):181–185.
  • Harris JP, Alexander TH. Current-day prevalence of Meniere’s syndrome. Audiol Neurootol. 2010;15(5):318–322. doi: 10.1159/000286213.
  • Nevoux J, Barbara M, Dornhoffer J, et al. International consensus (ICON) on treatment of Ménière’s disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(1S):S29–S32. doi: 10.1016/j.anorl.2017.12.006.
  • Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg. 1996;115(1):38–41. doi: 10.1016/S0194-5998(96)70133-X.
  • MacArthur C, Hausman F, Kempton B, et al. Intratympanic steroid treatments may improve hearing via ion homeostasis alterations and not immune suppression. Otol Neurotol. 2015;36(6):1089–1095. doi: 10.1097/MAO.0000000000000725.
  • Fukushima M, Kitahara T, Uno Y, et al. Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression. Acta Otolaryngol. 2002;122(6):600–606. doi: 10.1080/000164802320396268.
  • Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol. 2007;28(8):1124–1130. doi: 10.1097/MAO.0b013e31815aee21.
  • Lee JJ, Jang JH, Choo OS, et al. Steroid intracochlear distribution differs by administration method: systemic versus intratympanic injection. Laryngoscope. 2018;128(1):189–194. doi: 10.1002/lary.26562.
  • Casani AP, Piaggi P, Cerchiai N, et al. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg. 2012;146(3):430–437. doi: 10.1177/0194599811429432.
  • Patel M. Intratympanic corticosteroids in Ménière’s disease: a mini-review. J Otol. 2017;12(3):117–124. doi: 10.1016/j.joto.2017.06.002.
  • Atrache Al Attrache N, Krstulovic C, Pérez Guillen V, et al. Response over time of vertigo spells to intratympanic dexamethasone treatment in Meniere’s disease patients. J Int Adv Otol. 2016;12(1):92–97. doi: 10.5152/iao.2016.2177.
  • Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133(2):285–294. doi: 10.1016/j.otohns.2005.05.010.
  • Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19(2):196–201.
  • Lambert PR, Nguyen S, Maxwell KS, et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière’s disease. Otol Neurotol. 2012;33(7):1257–1265. doi: 10.1097/MAO.0b013e318263d35d.
  • Webster KE, Lee A, Galbraith K, et al. Intratympanic corticosteroids for Ménière’s disease. Cochrane Database Syst Rev. 2023;2(2):CD015245.
  • Boleas-Aguirre MS, Lin FR, Della Santina CC, et al. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière’s disease. Otol Neurotol. 2008;29(1):33–38. doi: 10.1097/mao.0b013e31815dbafc.
  • Gürkov R, Jerin C, Flatz W, et al. Clinical manifestations of hydropic ear disease (Menière’s). Eur Arch Otorhinolaryngol. 2019;276(1):27–40. doi: 10.1007/s00405-018-5157-3.
  • Leng Y, Liu B, Zhou R, et al. Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere’s disease. Acta Otolaryngol. 2017;137(2):154–160. doi: 10.1080/00016489.2016.1224920.
  • Yardley L, Kirby S. Evaluation of booklet-based self-management of symptoms in Ménière disease: a randomized controlled trial. Psychosom Med. 2006;68(5):762–769. doi: 10.1097/01.psy.0000232269.17906.92.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.